Page 30 of 39 · 913 questions tagged clinical-trials.
What I have: mazdutide · 40 °C. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am interested in…
Numbers first: STEP 8 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Details up front: a GLP-1 receptor agonist · 30 °C. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. Please show the division. I want to check my own against…
Details up front: SELECT · 40 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
For reference: STEP 5 · ecnoglutide. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The particulars: liraglutide · 37 °C. Somebody stated this to me confidently and I would like to check it before repeating it. I would accept a well-reasoned negative…
The particulars: SURMOUNT-2 · constipation · 8 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably…
The specifics, since they change the answer: oral semaglutide · minus 20 °C. Somebody stated this to me confidently and I would like to check it before repeating it.…
What I am working with: STEP 8 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report including…
Numbers first: SURMOUNT-1 · orforglipron. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Details up front: SURPASS-2 · orforglipron. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Details up front: STEP 1 · constipation. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
For reference: SURMOUNT-OSA · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
The specifics, since they change the answer: tirzepatide · room temperature. I would like to know whether this claim survives contact with evidence. If the answer is…
For reference: STEP 3 · 20 mg. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am being…
The specifics, since they change the answer: REDEFINE-1 · 20 mg. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I…
Numbers first: a GLP-1 receptor agonist · TRIUMPH-1. I suspect the usual explanation for this is wrong, or at least incomplete. I am aware this may have a boring…
Details up front: cagrilintide · tirzepatide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
I have read the prescribing information and it addresses the adjacent case but not this one. I can parse the result. I am less sure what it licenses me to conclude. I…
Numbers first: STEP 8 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
Concretely: STEP 8 · dizziness. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
I have three data points across nine months, which I hope is enough to see a trend. I would like the arithmetic checked rather than the conclusion asserted. I have…
Numbers first: TRIUMPH-1 · early satiety · 50 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear…